Domain-Alteration Chimera Strategy Suppresses Prostate Tumor Growth in Preclinical Tests
Preclinical experiments demonstrate that novel domain-alteration chimeras rewire oncogenic protein complexes, inhibiting prostate cancer growth while sparing healthy tissue.










